Anthropic Says Claude Autonomously Discovered New CRISPR-Like Enzyme System

The significance here lies less in the enzyme itself than in the claim of autonomy: an AI system generating a biological discovery that its own maker cannot yet interpret is a governance question as much as a scientific one. The affected parties span biosecurity regulators, research labs weighing AI-derived leads, and the AI firms now positioned as arbiters of unverified findings. What matters next is independent replication and functional characterization — until the mechanism is understood, the discovery's value and its risk profile remain equally undefined.